HLA-A02:01–Restricted Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP11/12 Preferentially Recall Polyfunctional Effector Memory CD8+T Cells from Seropositive Asymptomatic Individuals and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpes-Reference-Cited by-同舟云学术

HLA-A02:01–Restricted Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP11/12 Preferentially Recall Polyfunctional Effector Memory CD8+T Cells from Seropositive Asymptomatic Individuals and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpes

Published:2015-01-23 Issue:5 Volume:194 Page:2232-2248
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Srivastava Ruchi,Khan Arif A.,Spencer Doran,Vahed Hawa,Lopes Patricia P.,Thai Nhi Thi Uyen,Wang Christine,Pham Thanh T.,Huang Jiawei,Scarfone Vanessa M.,Nesburn Anthony B.,Wechsler Steven L.,BenMohamed Lbachir

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference77 articles.

1. Asymptomatic HLA-A*02:01–Restricted Epitopes from Herpes Simplex Virus Glycoprotein B Preferentially Recall Polyfunctional CD8+T Cells from Seropositive Asymptomatic Individuals and Protect HLA Transgenic Mice against Ocular Herpes

2. HLA-A*0201-Restricted CD8+Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D

3. Targeting the Genital Tract Mucosa with a Lipopeptide/Recombinant Adenovirus Prime/Boost Vaccine Induces Potent and Long-Lasting CD8+T Cell Immunity against Herpes: Importance of MyD88

4. Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: Implication for the development of an universal CD8+ T-cell epitope-based vaccine

5. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of HLA polymorphism on herpesvirus infection and disease;Immunogenetics;2023-01-03

2. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection;JAMA;2022-11-01

3. The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time;Pathogens;2021-11-12

4. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target;Archives of Virology;2021-08-14

5. Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge;Vaccine;2021-04